NOTA-AE105
Product Specifications
UNSPSC Description
NOTA-AE105 is an PET ligand of urokinase-type plasminogen activator receptor (uPAR), which can be radiolabeled by 64Cu and 68Ga. 68Ga-NOTA-AE105 and 64Cu-NOTA-AE105 shows high image contrast, resulting in clear tumor delineation[1][2].
Target Antigen
Radionuclide-Drug Conjugates (RDCs); Ser/Thr Protease
Type
Peptides
Related Pathways
Antibody-drug Conjugate/ADC Related;Metabolic Enzyme/Protease
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/nota-ae105.html
Purity
98.91
Solubility
DMSO : 66.67 mg/mL (ultrasonic)|DMSO : 83.33 mg/mL (ultrasonic)
Smiles
O=C(N[C@@H](CO)C(O)=O)[C@@H](NC([C@H](CC(C)C)NC([C@@H](NC([C@@H](CCCNC(N)=N)NC([C@@H](CO)NC([C@H](CC1=CC=CC=C1)NC([C@@H](NC([C@H](CC(O)=O)NC(CN(CCN2CC(O)=O)CCN(CC2)CC(O)=O)=O)=O)CC3CCCCC3)=O)=O)=O)=O)CC(C=C4)=CC=C4O)=O)=O)CC5=CNC6=CC=CC=C56
Molecular Weight
1511.68
References & Citations
[1]Risør LM, et al. Prognostic Value of Urokinase-Type Plasminogen Activator Receptor PET/CT in Head and Neck Squamous Cell Carcinomas and Comparison with 18F-FDG PET/CT: A Single-Center Prospective Study. J Nucl Med. 2022 Aug;63(8):1169-1176. |[2]Persson M, et al. uPAR is a promising new imaging biomarker in glioblastoma[J]. Journal of Nuclear Medicine, 2015.
Shipping Conditions
Blue Ice
Storage Conditions
-80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture and light, under nitrogen)
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-P5018/NOTA-AE105-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-P5018/NOTA-AE105-SDS-MedChemExpress.pdf
Clinical Information
No Development Reported
CAS Number
1820563-84-5
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
